Shusen Sun

2.0k total citations
85 papers, 1.4k citations indexed

About

Shusen Sun is a scholar working on Geriatrics and Gerontology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shusen Sun has authored 85 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Geriatrics and Gerontology, 19 papers in Pharmacology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shusen Sun's work include Pharmaceutical Practices and Patient Outcomes (21 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Shusen Sun is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (21 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Shusen Sun collaborates with scholars based in United States, China and United Kingdom. Shusen Sun's co-authors include Xingang Li, Long Meng, Zhigang Zhao, Feng Qiu, Tiansheng Wang, Zhicheng Gong, Shao Liu, Huilin Tang, Qin Hu and Mimi L.K. Tang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Shusen Sun

82 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shusen Sun United States 20 336 223 147 143 141 85 1.4k
Domenico Motola Italy 25 424 1.3× 157 0.7× 199 1.4× 198 1.4× 125 0.9× 87 1.7k
Janet Sultana Italy 24 242 0.7× 294 1.3× 159 1.1× 265 1.9× 237 1.7× 77 2.1k
Ju‐Yeun Lee South Korea 17 156 0.5× 280 1.3× 129 0.9× 134 0.9× 99 0.7× 135 1.2k
Daniel R. Morales United Kingdom 28 225 0.7× 127 0.6× 187 1.3× 204 1.4× 97 0.7× 83 2.3k
James McCormack Canada 27 367 1.1× 142 0.6× 189 1.3× 250 1.7× 111 0.8× 102 2.1k
Luisa Ibáñez Spain 21 248 0.7× 114 0.5× 171 1.2× 189 1.3× 45 0.3× 52 1.4k
R. Lassalle France 22 146 0.4× 117 0.5× 252 1.7× 141 1.0× 79 0.6× 98 2.4k
Peter I. Pillans Australia 29 307 0.9× 298 1.3× 115 0.8× 329 2.3× 221 1.6× 93 2.2k
Hitomi Teramachi Japan 16 161 0.5× 187 0.8× 63 0.4× 119 0.8× 91 0.6× 174 1.2k
Stefan Russmann Switzerland 26 195 0.6× 112 0.5× 125 0.9× 208 1.5× 87 0.6× 64 2.2k

Countries citing papers authored by Shusen Sun

Since Specialization
Citations

This map shows the geographic impact of Shusen Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shusen Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shusen Sun more than expected).

Fields of papers citing papers by Shusen Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shusen Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shusen Sun. The network helps show where Shusen Sun may publish in the future.

Co-authorship network of co-authors of Shusen Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Shusen Sun. A scholar is included among the top collaborators of Shusen Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shusen Sun. Shusen Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sun, Shusen, et al.. (2024). Pharmacogenomics education in China and the United States: advancing personalized medicine. Personalized Medicine. 22(1). 21–27.
3.
Liu, Kefeng, Zhirong Yang, Xiaojing Lu, et al.. (2023). The origin of vitamin B12 levels and risk of all-cause, cardiovascular and cancer specific mortality: A systematic review and dose-response meta-analysis. Archives of Gerontology and Geriatrics. 117. 105230–105230. 10 indexed citations
4.
Meng, Long, et al.. (2022). Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database. Journal of Clinical Sleep Medicine. 18(9). 2229–2235. 3 indexed citations
5.
Chen, Jinglan, et al.. (2022). Mortality-Related Risk Factors and Novel Antimicrobial Regimens for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review. Infection and Drug Resistance. Volume 15. 6907–6926. 22 indexed citations
6.
Zhang, Lu, Howard L. McLeod, Keke Liu, et al.. (2021). Effect of Physician-Pharmacist Participation in the Management of Ambulatory Cancer Pain Through a Digital Health Platform: Randomized Controlled Trial. JMIR mhealth and uhealth. 9(8). e24555–e24555. 15 indexed citations
7.
Meng, Long, et al.. (2021). Drug‐Related Problems among Hospitalized Surgical Elderly Patients in China. BioMed Research International. 2021(1). 8 indexed citations
8.
Zhang, Lu, et al.. (2021). Based on the Beers Criteria 2019 Edition Over‐the‐Counter Drugs Risk Confirmation of Elderly Chinese. BioMed Research International. 2021(1). 5524551–5524551. 3 indexed citations
9.
Meng, Long, Bing Yang, Feng Qiu, et al.. (2021). Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database. Frontiers in Medicine. 8. 594043–594043. 14 indexed citations
10.
Sun, Shusen, Jingkai Wei, Dandan Li, et al.. (2020). Dipeptidyl peptidase-4 inhibitors and risk of venous thromboembolism: data mining of FDA adverse event reporting system. International Journal of Clinical Pharmacy. 42(5). 1364–1368. 5 indexed citations
11.
Ma, Zhuo, et al.. (2020). Impact of ‘Chief-Pharmacist System’ on drug expenditures and rational drug use. International Journal of Clinical Pharmacy. 42(1). 167–173. 5 indexed citations
12.
Yang, Ranyao, et al.. (2020). Ginsenoside Rb1 Improves Cognitive Impairment Induced by Insulin Resistance through Cdk5/p35‐NMDAR‐IDE Pathway. BioMed Research International. 2020(1). 3905719–3905719. 23 indexed citations
13.
Huang, Jing, Long Meng, Bing Yang, et al.. (2020). Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System. Scientific Reports. 10(1). 4803–4803. 57 indexed citations
14.
Li, Qin, Dan Lv, Ming‐Kung Yeh, et al.. (2019). Drug-related problems among hospitalized patients with COPD in mainland China. International Journal of Clinical Pharmacy. 41(6). 1507–1515. 14 indexed citations
15.
Zeng, Shuangshuang, Dong Wang, Yuanliang Yan, et al.. (2019). Single-Center Analysis of the Potential Inappropriate Use of Intravenous Medications in Hospitalized Patients in China. Clinical Therapeutics. 41(8). 1631–1637.e4. 8 indexed citations
16.
Zhang, Sha, Long Meng, Feng Qiu, Jiadan Yang, & Shusen Sun. (2018). Medication-related risk factors associated with health-related quality of life among community-dwelling elderly in China. Patient Preference and Adherence. Volume 12. 529–537. 14 indexed citations
17.
Li, Xiaotong, et al.. (2018). Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database. International Journal of Clinical Pharmacy. 40(4). 921–927. 15 indexed citations
18.
Xing, Yan, Shusen Sun, Xiang Ma, et al.. (2017). Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance data. European Journal of Pediatrics. 177(1). 145–154. 23 indexed citations
19.
Li, Xingang, Shusen Sun, Shenghui Mei, et al.. (2015). Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients. Journal of Pharmaceutical Sciences. 104(11). 3960–3967. 35 indexed citations
20.
Sun, Shusen, et al.. (2015). An evaluation of clinical pharmacist service on a neurology care unit. International Journal of Clinical Pharmacy. 38(1). 30–33. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Domenico Motola Breakdown of academic impact, for papers by Janet Sultana Breakdown of academic impact, for papers by Ju‐Yeun Lee Breakdown of academic impact, for papers by Daniel R. Morales Breakdown of academic impact, for papers by James McCormack Breakdown of academic impact, for papers by Luisa Ibáñez Breakdown of academic impact, for papers by R. Lassalle Breakdown of academic impact, for papers by Peter I. Pillans Breakdown of academic impact, for papers by Hitomi Teramachi Breakdown of academic impact, for papers by Stefan Russmann
Rankless by CCL
2026